The MarketWatch News Department was not involved in the creation of this content.-- VYVGART(R) SC is first and only neonatal Fc receptor blocker approved to treat CIDP -- Authoriz ...

La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) Pre-Filled Syringe (PFS) is ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...

Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...

Here are three important regulatory changes affecting parenteral packaging that pharmaceutical companies need to be aware of ...

SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Health Canada has issued a ...

West Pharmaceutical Services (West) has unveiled its West Synchrony Prefillable Syringe (PFS) System at CPHI Worldwide in Frankfurt, Germany, offering a 'fully verified' platform from a single ...

While investment has slowed in radiopharmaceuticals, analysts predict increased interest to come as Novartis shows just how successful radiopharmaceuticals can be.

The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.

Heron Therapeutics, Inc. (NASDAQ: HRTX) Q3 2025 Earnings Call Transcript November 4, 2025 Heron Therapeutics, Inc. misses on ...

Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 ...

Medytox announced on the 4th that it participated in the academic conference 'ICLAS,' hosted by the Korean Society for Laser ...